Go Pro

Etzer Darout Analyst Performance

Managing Director & Senior Biotechnology Analyst at BMO Capital Markets

Etzer Darout is a stock analyst at BMO Capital Markets in the healthcare sector, covering 37 publicly traded companies. Over the past year, Etzer Darout has issued 152 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Etzer Darout's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Etzer Darout's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
172 Last 6 Years
Buy Recommendations
82.84% 140 Buy Ratings
Companies Covered
37 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.8%3 ratings
Buy81.1%137 ratings
Hold11.8%20 ratings
Sell5.3%9 ratings

Out of 169 total stock ratings issued by Etzer Darout at BMO Capital Markets, the majority (81.1%) have been Buy recommendations, followed by 11.8% Hold, 5.3% Sell, and 1.8% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
37 companies

Etzer Darout, an analyst at BMO Capital Markets, currently covers 37 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
37 companies
100.0%

Etzer Darout of BMO Capital Markets specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
34 companies
91.9%
PHARMACEUTICALS
3 companies
8.1%

Etzer Darout's Ratings History at BMO Capital Markets

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/1/2026Boost Price Target$147.75$180.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/1/2026Boost Price Target$147.75$190.00Outperform
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
8/18/2026Initiated Coverage$59.53$78.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/17/2026Boost Price Target$155.10$178.00Outperform
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
8/13/2026Reiterated Rating$114.90$128.00Overweight
TRAX
First Tracks Biotherapeutics
8/13/2026Boost Price Target$46.13$65.00Overweight
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2026Lower Price Target$21.83$78.00Overweight
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
8/7/2026Boost Price Target$19.75$30.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
8/7/2026Boost Price Target$6.17$13.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
8/7/2026Boost Price Target$41.56$53.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/6/2026Boost Price Target$137.32$153.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/4/2026Boost Price Target$251.58$270.00Overweight
Incyte Corporation stock logo
INCY
Incyte
7/29/2026Boost Price Target$129.93$139.00Overweight
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
7/28/2026Downgrade$76.50$77.00Equal Weight
TRAX
First Tracks Biotherapeutics
7/21/2026Boost Price Target$36.87$48.00Overweight
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
7/21/2026Initiated Coverage$47.49$74.00Overweight
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
7/21/2026Initiated Coverage$50.73$74.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
7/14/2026Boost Price Target$129.89$151.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
7/14/2026Boost Price Target$236.97$260.00Overweight
Incyte Corporation stock logo
INCY
Incyte
7/14/2026Boost Price Target$114.23$134.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
7/14/2026Boost Price Target$56.04$49.00Equal Weight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Reiterated Rating$123.24$124.00Equal Weight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Downgrade$123.35Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/27/2026Boost Price Target$237.41$253.00Overweight
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
5/20/2026Boost Price Target$12.07$27.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
5/13/2026Boost Price Target$9.57$20.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/13/2026Boost Price Target$65.58$75.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
5/8/2026Boost Price Target$46.45$55.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
5/8/2026Boost Price Target$33.05$48.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/6/2026Boost Price Target$212.26$234.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
5/1/2026Boost Price Target$19.86$37.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/27/2026Boost Price Target$82.33$160.00Overweight
TRAX
First Tracks Biotherapeutics
4/22/2026Initiated Coverage$17.00$40.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
4/22/2026Lower Price Target$51.82$63.00Overweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
4/20/2026Boost Price Target$3.46$6.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
4/20/2026Boost Price Target$203.42$225.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
4/20/2026Boost Price Target$44.89$45.00Equal Weight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
4/20/2026Downgrade$15.82$14.00Underweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
4/20/2026Upgrade$34.55$45.00Overweight
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/8/2026Boost Price Target$14.23$21.00Overweight
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/7/2026Boost Price Target$58.94$78.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/30/2026Reiterated Rating$52.87$53.00Equal Weight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/27/2026Downgrade$52.88Hold
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
3/24/2026Boost Price Target$115.07$148.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
3/19/2026Boost Price Target$102.06$119.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/19/2026Boost Price Target$4.86$16.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
3/13/2026Boost Price Target$39.79$50.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2026Lower Price Target$91.57$128.00Outperform
MacroGenics, Inc. stock logo
MGNX
MacroGenics
3/10/2026Boost Price Target$2.93$4.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
3/9/2026Reiterated Rating$185.40$224.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/4/2026Boost Price Target$56.22$79.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/4/2026Boost Price Target$45.78$70.00Outperform
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/3/2026Boost Price Target$44.31$53.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/27/2026Initiated Coverage$188.97$224.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
2/26/2026Boost Price Target$2.75$7.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
2/26/2026Boost Price Target$13.37$27.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/26/2026Boost Price Target$86.70$113.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
2/25/2026Boost Price Target$4.27$11.00Overweight
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/24/2026Boost Price Target$9.50$30.00Overweight
Incyte Corporation stock logo
INCY
Incyte
2/18/2026Boost Price Target$101.16$117.00Overweight
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/17/2026Set Price Target$7.47$26.00
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/4/2026Reiterated Rating$7.68$24.00Overweight
Incyte Corporation stock logo
INCY
Incyte
2/4/2026Boost Price Target$100.92$116.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
2/4/2026Boost Price Target$42.59$44.00Equal Weight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
2/4/2026Boost Price Target$6.07$10.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/21/2026Downgrade$57.61$58.00Equal Weight
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
1/20/2026Boost Price Target$21.43$28.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
1/20/2026Boost Price Target$5.39$8.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
1/20/2026Boost Price Target$45.68$78.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
12/17/2025Boost Price Target$16.55$26.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
12/17/2025Boost Price Target$44.32$52.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
12/17/2025Boost Price Target$91.54$108.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
12/17/2025Lower Price Target$14.65$29.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
12/17/2025Boost Price Target$2.25$10.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
12/17/2025Lower Price Target$2.26$5.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
12/17/2025Boost Price Target$11.90$18.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
12/17/2025Lower Price Target$45.03$55.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
12/17/2025Set Price Target$17.23$18.00
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
12/17/2025Upgrade$17.23$18.00Equal Weight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
12/17/2025Boost Price Target$26.61$24.00Underweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
12/17/2025Boost Price Target$2.82$10.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
12/9/2025Boost Price Target$40.23$56.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/9/2025Boost Price Target$94.30$119.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/25/2025Boost Price Target$28.04$36.00Overweight
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
11/24/2025Reiterated Rating$11.17$28.00Overweight
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
11/24/2025Boost Price Target$2.24$9.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
11/24/2025Boost Price Target$18.44$35.00Overweight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
11/17/2025Set Price Target$108.00$152.00
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/17/2025Boost Price Target$36.58$45.00Overweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
11/14/2025Reiterated Rating$37.47$50.00Outperform
Major Buy Alert Issued for September 30th (Ad)

Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.tc pixel

See which stocks his AI research platform is flagging now
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/11/2025Boost Price Target$19.12$28.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/11/2025Lower Price Target$33.98$70.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
11/11/2025Lower Price Target$22.98$21.00Underweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
11/7/2025Lower Price Target$28.60$56.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
11/7/2025Boost Price Target$78.49$88.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
11/7/2025Boost Price Target$25.63$48.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
11/6/2025Boost Price Target$9.82$16.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
11/5/2025Boost Price Target$59.91$70.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$37.90$41.00Equal Weight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/4/2025Boost Price Target$14.03$27.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
10/29/2025Upgrade$14.25$23.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
10/29/2025Upgrade$14.25$23.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
10/22/2025Lower Price Target$7.61$14.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
10/21/2025Boost Price Target$20.03$16.00Underweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
10/21/2025Boost Price Target$3.74$6.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/21/2025Boost Price Target$33.67$58.00Overweight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Set Price Target$6.69$5.00Equal Weight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Initiated Coverage$41.60$61.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/13/2025Set Price Target$26.79$35.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/13/2025Initiated Coverage$24.49$48.00Overweight
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
10/13/2025Set Price Target$87.82$125.00Overweight
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
10/13/2025Initiated Coverage$6.93$16.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
10/13/2025Initiated Coverage$31.37$78.00Overweight
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/13/2025Initiated Coverage$93.77$142.00Overweight
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
10/13/2025Initiated Coverage$26.77$25.00Underweight
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/13/2025Initiated Coverage$95.63$142.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
10/13/2025Initiated Coverage$32.46$78.00Overweight
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
10/13/2025Initiated Coverage$7.11$16.00Overweight
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
10/13/2025Initiated Coverage$102.05$125.00Overweight
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/13/2025Initiated Coverage$25.50$48.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/13/2025Initiated Coverage$26.35$35.00Overweight
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
10/13/2025Initiated Coverage$6.69$61.00Overweight
Merus N.V. stock logo
MRUS
Merus
9/30/2025Reiterated Rating$93.67$97.00Equal Weight
Merus N.V. stock logo
MRUS
Merus
9/30/2025Downgrade$94.15$97.00Equal Weight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/24/2025Lower Price Target$33.75$44.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/22/2025Boost Price Target$3.16$10.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
9/17/2025Initiated Coverage$8.62$6.00Underweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
9/17/2025Initiated Coverage$1.47$3.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
9/17/2025Initiated Coverage$39.14$40.00Equal Weight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
9/17/2025Initiated Coverage$1.96$3.50Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
9/17/2025Initiated Coverage$7.64$16.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/17/2025Initiated Coverage$7.30$15.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/17/2025Initiated Coverage$18.12$13.00Underweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/17/2025Initiated Coverage$32.34$45.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/17/2025Initiated Coverage$58.59$72.00Overweight
Merus N.V. stock logo
MRUS
Merus
9/17/2025Initiated Coverage$66.90$112.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/17/2025Initiated Coverage$48.78$60.00Overweight
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
9/17/2025Initiated Coverage$23.41$47.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/17/2025Initiated Coverage$3.41$8.00Overweight
Arvinas, Inc. stock logo
ARVN
Arvinas
9/16/2025Upgrade$7.61Strong-Buy
Labor Day Warning: The secret that called 1929 is flashing something new (Ad)

In 1929, a young researcher named Irving Weiss spotted warning signs Wall Street ignored - then watched the Dow crash nearly 13% in a single day, followed by another 12% drop the next. His research became Weiss Ratings, a system The Wall Street Journal ranked number one for investment performance. It also called the Dot-Com Bust, the 2008 crisis, and the 2020 crash. Now the system is flagging a possible shift in the back half of 2026, separating stocks it flags as vulnerable from those positioned to climb.tc pixel

Unlock full access to Weiss Ratings PLUS at 89 percent off
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
9/16/2025Initiated Coverage$3.38$8.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
9/16/2025Upgrade$1.93Strong-Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
9/16/2025Upgrade$40.44Hold
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
9/16/2025Initiated Coverage$23.46$47.00Overweight
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/16/2025Initiated Coverage$48.12$60.00Overweight
MacroGenics, Inc. stock logo
MGNX
MacroGenics
9/16/2025Upgrade$1.53Strong-Buy
Merus N.V. stock logo
MRUS
Merus
9/16/2025Initiated Coverage$68.18$112.00Overweight
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
9/16/2025Initiated Coverage$59.22$72.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/16/2025Initiated Coverage$18.09$13.00Underweight
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/16/2025Initiated Coverage$31.95$45.00Overweight
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
9/16/2025Initiated Coverage$7.40$15.00Overweight
Xencor, Inc. stock logo
XNCR
Xencor
9/16/2025Upgrade$9.25Strong Sell
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
9/2/2025Boost Price Target$6.19$13.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
8/7/2025Lower Price Target$34.62$45.00Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
5/13/2025Lower Price Target$2.93$15.00Outperform
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
4/4/2025Lower Price Target$3.26$9.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/12/2025Set Price Target$8.51$20.00Outperform
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2025Boost Price Target$105.35$143.00Outperform
Arvinas, Inc. stock logo
ARVN
Arvinas
2/12/2025Reiterated Rating$18.88$82.00Outperform